WE SOLD A BIOPEN SYSTEM TO UNIVERSITY OF CAMBRIDGE
We have sold a BioPen® Prime System to University of Cambridge in UK. The BioPen® System enables researchers to specifically expose individual cells, parts of cells and tissues to very small amounts of drugs. University of Cambridge is one of the world’s most prestigious universities and the customer relationship is expected to further strengthen Fluicell’s brand.
CEO Victoire Viannay comments:
“We are very proud to have established a customer relationship with University of Cambridge, one of the world’s most prestigious universities, which gives us another well-known reference customer. In mid-May, we welcomed a doctoral student from the university, who wanted to test our system for a specific type of experiment. Everything went according to expectations and she convinced the technology’s capabilities. We were very happy to have her with us for three days and look forward to the upcoming results.”